Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
P2Y12 inhibitor monotherapy versus dual antiplatelet therapy in patients with acute coronary syndromes undergoing coronary stenting: rationale and design of the NEOMINDSET Trial
Patrícia O. Guimarães, Marcelo Franken, Caio A.M. Tavares, Fábio Serra Silveira, Murillo de Oliveira Antunes, Ricardo Reinaldo Bergo, Rodrigo M Joaquim, Jessica C S Hirai, Pedro Beraldo de Andrade, Fábio Grunspun Pitta, José Mariani, Bruno Ramos Nascimento, João Eduardo Tinoco de Paula, Marcos S. Silveira, Tiberio A O Costa, Frederico Toledo Campo Dall’Orto, Renato G Serpa, Fernanda B A Sampaio, Louis N Ohe, Fernanda Mangione, Remo H.M. Furtado, Rogério Sarmento‐Leite, Frederico Monfardini, Silvia Regina Lamas Assis, José Carlos Nicolau, Andrei C. Spósito, Renato D. Lópes, Yoshinobu Onuma, Marco Valgimigli, Dominick J. Angiolillo, Patrick W. Serruys, Otávio Berwanger, Fernando Bacal, Pedro A. Lemos (2023). P2Y12 inhibitor monotherapy versus dual antiplatelet therapy in patients with acute coronary syndromes undergoing coronary stenting: rationale and design of the NEOMINDSET Trial. EuroIntervention, 19(4), pp. e323-e329, DOI: 10.4244/eij-d-23-00125.
Article285 days agoRisk and timing of clinical events according to diabetic status of patients treated with everolimus‐eluting bioresorbable vascular scaffolds versus everolimus‐eluting stent: 2‐year results from a propensity score matched comparison of ABSORB EXTEND and SPIRIT trials
Carlos M. Campos, Adriano Caixeta, Marcelo Franken, Antonio L. Bartorelli, Robert Whitbourn, Chiung‐Jen Wu, Hsien‐Li Kao, Mohd Ali Rosli, Didier Carrié, Bernard De Bruyne, Gregg W. Stone, Patrick W. Serruys, Alexandre Abizaid (2017). Risk and timing of clinical events according to diabetic status of patients treated with everolimus‐eluting bioresorbable vascular scaffolds versus everolimus‐eluting stent: 2‐year results from a propensity score matched comparison of ABSORB EXTEND and SPIRIT trials. Catheterization and Cardiovascular Interventions, 91(3), pp. 387-395, DOI: 10.1002/ccd.27109.
Article285 days agoPotent P2Y12 Inhibitor Monotherapy vs DAPT After PCI in Patients With and Without STEMI
Caio A.M. Tavares, Patrícia O. Guimarães, Marcelo Franken, José Mariani, Stefano G.D. Lemos, Breno Oliveira Almeida, Eduardo B. Martins, Estêvão Lanna Figueiredo, A ROCHA, Alexandre Soares, Marcos Maynar-Mariño, Bruno Paolino, Mayler Olombrada Nunes de Santos, Paulo Caramori, Rodrigo M Joaquim, Edgar Freitas Quintella, André F.de P. Antonangelo, A. Fonseca, Marcos S. Silveira, Marta Fonseca, Frederico Monfardini, Silvia R.L. Assis, L. Costa, José Carlos Nicolau, Andrei C. Spósito, Renato D. Lopes, Yoshinobu Onuma, Marco Valgimigli, Dominick J. Angiolillo, Patrick W. Serruys, Otávio Berwanger, Raúl D. Santos, Fernando Bacal, Pedro A. Lemos (2025). Potent P2Y12 Inhibitor Monotherapy vs DAPT After PCI in Patients With and Without STEMI. , DOI: https://doi.org/10.1016/j.jacc.2025.10.058.
Article43 days agoPrasugrel or ticagrelor monotherapy vs dual antiplatelet treatment after percutaneous coronary intervention in acute coronary syndromes: a landmark analysis from the NEOMINDSET trial
Caio de Assis Moura Tavares, Patrícia O. Guimarães, Marcelo Franken, Karla Santo, Guy F. A. Prado, Felipe Bezerra, Vagner Madrini, Willterson Carlos Bandeira, G S Délcio, Gabriela Montenegro, J Forte, Walter Alvarenga, Fernando De Martino, Marcos Mitsuo Seki, José Francisco Kerr Saraiva, J Saad, Adriano Caixeta, João Luiz de Alencar Araripe Falcão, Weimar Kunz Sebba Barroso, George César Ximenes Meireles, Thiago Braido Dias, Frederico Monfardini, Silvia R.L. Assis, José Carlos Nicolau, Andrei C. Spósito, Renato D. Lópes, Yoshinobu Onuma, Marco Valgimigli, Dominick J. Angiolillo, Patrick W. Serruys, Otávio Berwanger, Fernando Bacal, Pedro A. Lemos (2025). Prasugrel or ticagrelor monotherapy vs dual antiplatelet treatment after percutaneous coronary intervention in acute coronary syndromes: a landmark analysis from the NEOMINDSET trial. , DOI: https://doi.org/10.1093/eurheartj/ehaf1050.
Article43 days agoEarly Withdrawal of Aspirin after PCI in Acute Coronary Syndromes
Patrícia O. Guimarães, Marcelo Franken, Caio A.M. Tavares, Murillo de Oliveira Antunes, Fábio Serra Silveira, Pedro Beraldo de Andrade, Ricardo Reinaldo Bergo, Rodrigo M Joaquim, João Eduardo Tinoco de Paula, Bruno Ramos Nascimento, Fábio Grunspun Pitta, José Alcides Almeida de Arruda, Renato Giestas Serpa, Louis Nakayama Ohe, Fernanda Mangione, Remo H.M. Furtado, Esmeralci Ferreira, Fernanda B A Sampaio, C NASCIMENTO, Luiz O.O. Genelhu, Cristiano Guedes Bezerra, Rogério Sarmento‐Leite, Lília Nigro Maia, Flávio Roberto Azevedo de Oliveira, Marco Vugman Wainstein, Frederico Toledo Campo Dall’Orto, Frederico Monfardini, Silvia R.L. Assis, José Carlos Nicolau, Andrei C. Spósito, Renato D. Lópes, Yoshinobu Onuma, Marco Valgimigli, Dominick J. Angiolillo, Patrick W. Serruys, Otávio Berwanger, Fernando Bacal, Pedro A. Lemos (2025). Early Withdrawal of Aspirin after PCI in Acute Coronary Syndromes. , 393(21), DOI: https://doi.org/10.1056/nejmoa2507980.
Article43 days ago